RenovoRx Past Performance
How has RenovoRx performed over the past 5 years?
Past Performance Score0/6
Past Performance Score 0/6
Growing Profit Margin
Earnings vs Industry
Last years earnings growth
Earnings and Revenue History
Quality Earnings: RNXT is currently unprofitable.
Growing Profit Margin: RNXT is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if RNXT's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Unable to compare RNXT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: RNXT is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (53%).
Return on Equity
High ROE: RNXT has a negative Return on Equity (-123.81%), as it is currently unprofitable.